Cargando…
Immunemodulatory Effects of 5-Azacitidin Through Expansion of Functional Regulatory T Cells on Paraneoplastic Inflammation Associated With Myelodysplastic Syndromes: A Case Report
Myelodysplastic syndrome (MDS) is a heterogeneous group of clonal disorders of hematopoietic stem cells, characterized by dysplastic hematopoiesis and dysregulated immune system resulting in various clinical conditions. Paraneoplastic inflammatory syndromes, which are well known to be associated wit...
Autores principales: | Serizawa, Kentaro, Tanaka, Hirokazu, Morita, Yasuyoshi, Taniguchi, Takahide, Ashida, Takashi, Matsumura, Itaru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996049/ https://www.ncbi.nlm.nih.gov/pubmed/29922595 http://dx.doi.org/10.3389/fonc.2018.00204 |
Ejemplares similares
-
Severe Eosinophilia in Myelodysplastic Syndrome With a Defined and Rare Cytogenetic Abnormality
por: Rai, Shinya, et al.
Publicado: (2019) -
Synchronous Occurrence of Mycosis Fungoides, Diffuse Large B Cell Lymphoma and Acute Myeloid Leukemia
por: Miyatake, Junichi, et al.
Publicado: (2018) -
Long-term effectiveness and safety of high dose chemotherapy followed by
autologous stem cell transplantation in daily practice in patients with diffuse large
B-cell lymphoma
por: Haeno, Takahiro, et al.
Publicado: (2023) -
Five‐day regimen of azacitidine for lower‐risk myelodysplastic syndromes (refractory anemia or refractory anemia with ringed sideroblasts): A prospective single‐arm phase 2 trial
por: Morita, Yasuyoshi, et al.
Publicado: (2018) -
Secondary Pulmonary Alveolar Proteinosis Following Treatment with Azacitidine for Myelodysplastic Syndrome
por: Hashimoto, Miki, et al.
Publicado: (2019)